XML 83 R26.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Major Customers, Partnerships and Strategic Alliances (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2014
Biogen [Member] |
Revenues Recognized under Agreement | Revenues recognized under the Biogen Agreement for the twelve months ended December 31, 2014 are as follows (in thousands):
|  | Year ended |
|  | December 31, |
|  | 2014 |
Revenue related to Biogen Collaboration: |  |  |  |
Recognition of upfront fee |  | $ | 5,313 |
Research services |  |  | 7,751 |
Total |  | $ | 13,064 |
Shire AG [Member] |
Revenues Recognized under Agreement | Revenues recognized under the Shire Agreement for the years ended December 31, 2014, 2013 and 2012, were as follows (in thousands):
|  | Year ended December 31, |
|  | 2014 |  |  | 2013 |  |  | 2012 |
Revenue related to Shire Collaboration: |  |  |  |  |  |  |  |  |  |  |  |
Recognition of upfront fee |  | $ | 2,167 |  |  | $ | 2,167 |  |  | $ | 1,986 |
Recognition of milestone |  |  | 1,000 |  |  |  | — |  |  |  | — |
Research services |  |  | 22,765 |  |  |  | 14,286 |  |  |  | 9,026 |
Total |  | $ | 25,932 |  |  | $ | 16,453 |  |  | $ | 11,012 |
Sigma-Aldrich Corporation [Member] |
Revenues Recognized under Agreement | Revenues recognized under the agreement with Sigma for the years ended December 31, 2014, 2013 and 2012, were as follows (in thousands):
|  | Year ended December 31, |
|  | 2014 |  |  | 2013 |  |  | 2012 |
Revenue related to Sigma Collaboration: |  |  |  |  |  |  |  |  |  |  |  |
Royalty revenues |  | $ | 344 |  |  | $ | 824 |  |  | $ | 1,288 |
License fee and milestone revenues |  |  | 448 |  |  |  | 1,351 |  |  |  | 1,000 |
Total |  | $ | 792 |  |  | $ | 2,175 |  |  | $ | 2,288 |

X
- Definition Tabular disclosure of contractual arrangements that involve two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity. Additionally, the element may include all other transactions of the entity categorized collectively, if such comparison of collaborative arrangements as a component of all transactions of the entity is desired. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=sgmo_BiogenIdecIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=sgmo_ShireAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=sgmo_SigmaAldrichCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |